Compare SMTI & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SMTI | HRZN |
|---|---|---|
| Founded | 1982 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 182.6M | 195.5M |
| IPO Year | 2008 | N/A |
| Metric | SMTI | HRZN |
|---|---|---|
| Price | $18.00 | $4.74 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 6 |
| Target Price | ★ $36.00 | $6.67 |
| AVG Volume (30 Days) | 62.9K | ★ 614.9K |
| Earning Date | 05-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 28.88% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,586,976.00 | N/A |
| Revenue This Year | $17.31 | $12.25 |
| Revenue Next Year | $12.48 | $22.53 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.47 | N/A |
| 52 Week Low | $16.05 | $4.00 |
| 52 Week High | $35.70 | $8.81 |
| Indicator | SMTI | HRZN |
|---|---|---|
| Relative Strength Index (RSI) | 52.62 | 53.86 |
| Support Level | $16.05 | $4.01 |
| Resistance Level | $21.14 | $6.77 |
| Average True Range (ATR) | 1.13 | 0.15 |
| MACD | 0.16 | 0.12 |
| Stochastic Oscillator | 99.37 | 97.95 |
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.